Skip to main content

Table 3 Chi square comparative HIV treatment outcomes among the study patients by PI prescription

From: Adoption of evidence-informed guidelines in prescribing protease inhibitors for HIV-Tuberculosis co-infected patients on rifampicin and effects on HIV treatment outcomes in Uganda

 

Appropriate PI prescription n (%)

Inappropriate PI prescription n (%)

p-value

2-year post TB treatment HIV clinical outcome (N = 248)

N = 21

N = 227

0.318

 Alive in care

13 (61.9)

146 (64.3)

 

 Dead

1 (4.8)

13 (5.7)

 

 LTFU

5 (23.8)

43 (18.9)

 

 TO

2 (9.5)

25 (11.0)

 

Missed ART days during TB treatment, (N = 602)

N = 103

N = 499

0.001

 None

66 (64.1)

394 (79.0)

 

 Missed

37 (35.9)

105 (21.0)

 

Closest viral load post TB treatment

(within 1 year) ( N = 218)

N = 19

N = 199

0.471

 Suppressed

13 (68.4)

138 (69.4)

 

 Virologic failure

6 (31.6)

61 (30.7)

 
  1. LTFU loss to follow up, TO Transferred out, Appropriate PI prescription LPV/r 800/ 200 mg BID, inappropriate PI prescription prescription of LPV/r 400/100 mg BID or a prescription of ATV/r, ART Antiretroviral therapy